Compass Therapeutics Stock Probability of Future Stock Price Finishing Under 1.7
| CMPX Stock | USD 1.50 0.01 0.67% |
Compass |
Compass Therapeutics Target Price Odds to finish below 1.7
The tendency of Compass Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.70 after 90 days |
| 1.50 | 90 days | 1.70 | about 55.83 |
Based on a normal probability distribution, the odds of Compass Therapeutics to stay under $ 1.70 after 90 days from now is about 55.83 (This Compass Therapeutics probability density function shows the probability of Compass Stock to fall within a particular range of prices over 90 days) . Probability of Compass Therapeutics price to stay between its current price of $ 1.50 and $ 1.70 at the end of the 90-day period is about 36.19 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.21 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Compass Therapeutics will likely underperform. Additionally Compass Therapeutics has an alpha of 0.0199, implying that it can generate a 0.0199 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Compass Therapeutics Price Density |
| Price |
Predictive Modules for Compass Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Compass Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Compass Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Compass Therapeutics is not an exception. The market had few large corrections towards the Compass Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Compass Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Compass Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 3.21 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | 0.05 |
Compass Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Compass Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Compass Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Compass Therapeutics is way too risky over 90 days horizon | |
| Compass Therapeutics may become a speculative penny stock | |
| Compass Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (42.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Compass Therapeutics currently holds about 132.02 M in cash with (40.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. | |
| Compass Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Janus Henderson Group PLCs Strategic Reduction in Compass Therapeutics Inc Holdings |
Compass Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Compass Stock often depends not only on the future outlook of the current and potential Compass Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Compass Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 127 M | |
| Cash And Short Term Investments | 152.5 M |
Compass Therapeutics Technical Analysis
Compass Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Compass Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Compass Therapeutics. In general, you should focus on analyzing Compass Stock price patterns and their correlations with different microeconomic environments and drivers.
Compass Therapeutics Predictive Forecast Models
Compass Therapeutics' time-series forecasting models is one of many Compass Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Compass Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Compass Therapeutics
Checking the ongoing alerts about Compass Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Compass Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Compass Therapeutics is way too risky over 90 days horizon | |
| Compass Therapeutics may become a speculative penny stock | |
| Compass Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (42.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Compass Therapeutics currently holds about 132.02 M in cash with (40.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. | |
| Compass Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Janus Henderson Group PLCs Strategic Reduction in Compass Therapeutics Inc Holdings |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.